Sangamo Wins OK For Cheaper $35M Ch. 11 Loan
By Ben Zigterman · July 23, 2026, 1:11 PM EDT
Biotechnology company Sangamo Therapeutics received interim approval Thursday to tap into a new, $35 million Chapter 11 financing package with a lower interest rate....
To view the full article, register now.